Learning Objectives
After completing this educational activity, the learner should be better able to:

• Review the guidelines for the treatment of the invasive infections caused by Aspergillus species.
• Describe the value of Amphotericin B (AmB), lipid formulations of AmB, itraconazole, posaconazole, voriconazole, caspofungin, anidulafungin, and micafungin in the treatment of invasive aspergillosis.
• Recognize that treatment options differ between various infection sites and that surgical intervention can be a critical component of therapy.
• Discuss the importance of reversal of immunosuppression and close monitoring in the management of invasive aspergillosis.

Target Audience
This learning activity is intended for oncologists, hematologists, infectious disease specialists who treat transplant patients and other patient populations at risk for developing fungal infections.